 | • レポートコード：MRC2-11QY03846 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はモノクローナル抗体サービスのグローバル市場について調査・分析したレポートです。種類別（試薬、医薬品、その他）市場規模、用途別（診断研究所、研究所、学術研究所、製薬・バイオテクノロジー企業）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別モノクローナル抗体サービスの競争状況、市場シェア ・世界のモノクローナル抗体サービス市場：種類別市場規模 2015年-2020年（試薬、医薬品、その他） ・世界のモノクローナル抗体サービス市場：種類別市場規模予測 2021年-2026年（試薬、医薬品、その他） ・世界のモノクローナル抗体サービス市場：用途別市場規模 2015年-2020年（診断研究所、研究所、学術研究所、製薬・バイオテクノロジー企業） ・世界のモノクローナル抗体サービス市場：用途別市場規模予測 2021年-2026年（診断研究所、研究所、学術研究所、製薬・バイオテクノロジー企業） ・北米のモノクローナル抗体サービス市場分析：米国、カナダ ・ヨーロッパのモノクローナル抗体サービス市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのモノクローナル抗体サービス市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のモノクローナル抗体サービス市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのモノクローナル抗体サービス市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Roche、Eli Lilly、Bayer、Amgen、Sanofi-Aventis、Johnson & Johnson、Novo Nordisk、Merck、Abbott Laboratories、GSK、BMS、Alexion、UCB、Seattle Genetics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Monoclonal Antibody Service Market
The global Monoclonal Antibody Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Monoclonal Antibody Service Scope and Market Size
Monoclonal Antibody Service market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Roche
Eli Lilly
Bayer
Amgen
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Merck
Abbott Laboratories
GSK
BMS
Alexion
UCB
Seattle Genetics
Market segment by Type, the product can be split into
Reagents
Drugs
Other
Market segment by Application, split into
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Monoclonal Antibody Service Revenue
1.4 Market by Type
1.4.1 Global Monoclonal Antibody Service Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Reagents
1.4.3 Drugs
1.4.4 Other
1.5 Market by Application
1.5.1 Global Monoclonal Antibody Service Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Laboratories
1.5.3 Research & Academic Laboratories
1.5.4 Pharmaceutical & Biotechnology Companies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Service Market Perspective (2015-2026)
2.2 Global Monoclonal Antibody Service Growth Trends by Regions
2.2.1 Monoclonal Antibody Service Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Monoclonal Antibody Service Historic Market Share by Regions (2015-2020)
2.2.3 Monoclonal Antibody Service Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Monoclonal Antibody Service Market Growth Strategy
2.3.6 Primary Interviews with Key Monoclonal Antibody Service Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Service Players by Market Size
3.1.1 Global Top Monoclonal Antibody Service Players by Revenue (2015-2020)
3.1.2 Global Monoclonal Antibody Service Revenue Market Share by Players (2015-2020)
3.1.3 Global Monoclonal Antibody Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Monoclonal Antibody Service Market Concentration Ratio
3.2.1 Global Monoclonal Antibody Service Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Service Revenue in 2019
3.3 Monoclonal Antibody Service Key Players Head office and Area Served
3.4 Key Players Monoclonal Antibody Service Product Solution and Service
3.5 Date of Enter into Monoclonal Antibody Service Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Monoclonal Antibody Service Historic Market Size by Type (2015-2020)
4.2 Global Monoclonal Antibody Service Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Monoclonal Antibody Service Market Size by Application (2015-2020)
5.2 Global Monoclonal Antibody Service Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Monoclonal Antibody Service Market Size (2015-2020)
6.2 Monoclonal Antibody Service Key Players in North America (2019-2020)
6.3 North America Monoclonal Antibody Service Market Size by Type (2015-2020)
6.4 North America Monoclonal Antibody Service Market Size by Application (2015-2020)
7 Europe
7.1 Europe Monoclonal Antibody Service Market Size (2015-2020)
7.2 Monoclonal Antibody Service Key Players in Europe (2019-2020)
7.3 Europe Monoclonal Antibody Service Market Size by Type (2015-2020)
7.4 Europe Monoclonal Antibody Service Market Size by Application (2015-2020)
8 China
8.1 China Monoclonal Antibody Service Market Size (2015-2020)
8.2 Monoclonal Antibody Service Key Players in China (2019-2020)
8.3 China Monoclonal Antibody Service Market Size by Type (2015-2020)
8.4 China Monoclonal Antibody Service Market Size by Application (2015-2020)
9 Japan
9.1 Japan Monoclonal Antibody Service Market Size (2015-2020)
9.2 Monoclonal Antibody Service Key Players in Japan (2019-2020)
9.3 Japan Monoclonal Antibody Service Market Size by Type (2015-2020)
9.4 Japan Monoclonal Antibody Service Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Monoclonal Antibody Service Market Size (2015-2020)
10.2 Monoclonal Antibody Service Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Monoclonal Antibody Service Market Size by Type (2015-2020)
10.4 Southeast Asia Monoclonal Antibody Service Market Size by Application (2015-2020)
11 India
11.1 India Monoclonal Antibody Service Market Size (2015-2020)
11.2 Monoclonal Antibody Service Key Players in India (2019-2020)
11.3 India Monoclonal Antibody Service Market Size by Type (2015-2020)
11.4 India Monoclonal Antibody Service Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Monoclonal Antibody Service Market Size (2015-2020)
12.2 Monoclonal Antibody Service Key Players in Central & South America (2019-2020)
12.3 Central & South America Monoclonal Antibody Service Market Size by Type (2015-2020)
12.4 Central & South America Monoclonal Antibody Service Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Monoclonal Antibody Service Introduction
13.1.4 Pfizer Revenue in Monoclonal Antibody Service Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Monoclonal Antibody Service Introduction
13.2.4 Roche Revenue in Monoclonal Antibody Service Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Monoclonal Antibody Service Introduction
13.3.4 Eli Lilly Revenue in Monoclonal Antibody Service Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Bayer
13.4.1 Bayer Company Details
13.4.2 Bayer Business Overview
13.4.3 Bayer Monoclonal Antibody Service Introduction
13.4.4 Bayer Revenue in Monoclonal Antibody Service Business (2015-2020)
13.4.5 Bayer Recent Development
13.5 Amgen
13.5.1 Amgen Company Details
13.5.2 Amgen Business Overview
13.5.3 Amgen Monoclonal Antibody Service Introduction
13.5.4 Amgen Revenue in Monoclonal Antibody Service Business (2015-2020)
13.5.5 Amgen Recent Development
13.6 Sanofi-Aventis
13.6.1 Sanofi-Aventis Company Details
13.6.2 Sanofi-Aventis Business Overview
13.6.3 Sanofi-Aventis Monoclonal Antibody Service Introduction
13.6.4 Sanofi-Aventis Revenue in Monoclonal Antibody Service Business (2015-2020)
13.6.5 Sanofi-Aventis Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Monoclonal Antibody Service Introduction
13.7.4 Johnson & Johnson Revenue in Monoclonal Antibody Service Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 Novo Nordisk
13.8.1 Novo Nordisk Company Details
13.8.2 Novo Nordisk Business Overview
13.8.3 Novo Nordisk Monoclonal Antibody Service Introduction
13.8.4 Novo Nordisk Revenue in Monoclonal Antibody Service Business (2015-2020)
13.8.5 Novo Nordisk Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck Monoclonal Antibody Service Introduction
13.9.4 Merck Revenue in Monoclonal Antibody Service Business (2015-2020)
13.9.5 Merck Recent Development
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Details
13.10.2 Abbott Laboratories Business Overview
13.10.3 Abbott Laboratories Monoclonal Antibody Service Introduction
13.10.4 Abbott Laboratories Revenue in Monoclonal Antibody Service Business (2015-2020)
13.10.5 Abbott Laboratories Recent Development
13.11 GSK
10.11.1 GSK Company Details
10.11.2 GSK Business Overview
10.11.3 GSK Monoclonal Antibody Service Introduction
10.11.4 GSK Revenue in Monoclonal Antibody Service Business (2015-2020)
10.11.5 GSK Recent Development
13.12 BMS
10.12.1 BMS Company Details
10.12.2 BMS Business Overview
10.12.3 BMS Monoclonal Antibody Service Introduction
10.12.4 BMS Revenue in Monoclonal Antibody Service Business (2015-2020)
10.12.5 BMS Recent Development
13.13 Alexion
10.13.1 Alexion Company Details
10.13.2 Alexion Business Overview
10.13.3 Alexion Monoclonal Antibody Service Introduction
10.13.4 Alexion Revenue in Monoclonal Antibody Service Business (2015-2020)
10.13.5 Alexion Recent Development
13.14 UCB
10.14.1 UCB Company Details
10.14.2 UCB Business Overview
10.14.3 UCB Monoclonal Antibody Service Introduction
10.14.4 UCB Revenue in Monoclonal Antibody Service Business (2015-2020)
10.14.5 UCB Recent Development
13.15 Seattle Genetics
10.15.1 Seattle Genetics Company Details
10.15.2 Seattle Genetics Business Overview
10.15.3 Seattle Genetics Monoclonal Antibody Service Introduction
10.15.4 Seattle Genetics Revenue in Monoclonal Antibody Service Business (2015-2020)
10.15.5 Seattle Genetics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Monoclonal Antibody Service Key Market Segments
Table 2. Key Players Covered: Ranking by Monoclonal Antibody Service Revenue
Table 3. Ranking of Global Top Monoclonal Antibody Service Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Monoclonal Antibody Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Reagents
Table 6. Key Players of Drugs
Table 7. Key Players of Other
Table 8. Global Monoclonal Antibody Service Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Monoclonal Antibody Service Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Monoclonal Antibody Service Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Monoclonal Antibody Service Market Share by Regions (2015-2020)
Table 12. Global Monoclonal Antibody Service Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Monoclonal Antibody Service Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Monoclonal Antibody Service Market Growth Strategy
Table 18. Main Points Interviewed from Key Monoclonal Antibody Service Players
Table 19. Global Monoclonal Antibody Service Revenue by Players (2015-2020) (Million US$)
Table 20. Global Monoclonal Antibody Service Market Share by Players (2015-2020)
Table 21. Global Top Monoclonal Antibody Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Service as of 2019)
Table 22. Global Monoclonal Antibody Service by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Monoclonal Antibody Service Product Solution and Service
Table 25. Date of Enter into Monoclonal Antibody Service Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Monoclonal Antibody Service Market Size by Type (2015-2020) (Million US$)
Table 28. Global Monoclonal Antibody Service Market Size Share by Type (2015-2020)
Table 29. Global Monoclonal Antibody Service Revenue Market Share by Type (2021-2026)
Table 30. Global Monoclonal Antibody Service Market Size Share by Application (2015-2020)
Table 31. Global Monoclonal Antibody Service Market Size by Application (2015-2020) (Million US$)
Table 32. Global Monoclonal Antibody Service Market Size Share by Application (2021-2026)
Table 33. North America Key Players Monoclonal Antibody Service Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Monoclonal Antibody Service Market Share (2019-2020)
Table 35. North America Monoclonal Antibody Service Market Size by Type (2015-2020) (Million US$)
Table 36. North America Monoclonal Antibody Service Market Share by Type (2015-2020)
Table 37. North America Monoclonal Antibody Service Market Size by Application (2015-2020) (Million US$)
Table 38. North America Monoclonal Antibody Service Market Share by Application (2015-2020)
Table 39. Europe Key Players Monoclonal Antibody Service Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Monoclonal Antibody Service Market Share (2019-2020)
Table 41. Europe Monoclonal Antibody Service Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Monoclonal Antibody Service Market Share by Type (2015-2020)
Table 43. Europe Monoclonal Antibody Service Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Monoclonal Antibody Service Market Share by Application (2015-2020)
Table 45. China Key Players Monoclonal Antibody Service Revenue (2019-2020) (Million US$)
Table 46. China Key Players Monoclonal Antibody Service Market Share (2019-2020)
Table 47. China Monoclonal Antibody Service Market Size by Type (2015-2020) (Million US$)
Table 48. China Monoclonal Antibody Service Market Share by Type (2015-2020)
Table 49. China Monoclonal Antibody Service Market Size by Application (2015-2020) (Million US$)
Table 50. China Monoclonal Antibody Service Market Share by Application (2015-2020)
Table 51. Japan Key Players Monoclonal Antibody Service Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Monoclonal Antibody Service Market Share (2019-2020)
Table 53. Japan Monoclonal Antibody Service Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Monoclonal Antibody Service Market Share by Type (2015-2020)
Table 55. Japan Monoclonal Antibody Service Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Monoclonal Antibody Service Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Monoclonal Antibody Service Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Monoclonal Antibody Service Market Share (2019-2020)
Table 59. Southeast Asia Monoclonal Antibody Service Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Monoclonal Antibody Service Market Share by Type (2015-2020)
Table 61. Southeast Asia Monoclonal Antibody Service Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Monoclonal Antibody Service Market Share by Application (2015-2020)
Table 63. India Key Players Monoclonal Antibody Service Revenue (2019-2020) (Million US$)
Table 64. India Key Players Monoclonal Antibody Service Market Share (2019-2020)
Table 65. India Monoclonal Antibody Service Market Size by Type (2015-2020) (Million US$)
Table 66. India Monoclonal Antibody Service Market Share by Type (2015-2020)
Table 67. India Monoclonal Antibody Service Market Size by Application (2015-2020) (Million US$)
Table 68. India Monoclonal Antibody Service Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Monoclonal Antibody Service Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Monoclonal Antibody Service Market Share (2019-2020)
Table 71. Central & South America Monoclonal Antibody Service Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Monoclonal Antibody Service Market Share by Type (2015-2020)
Table 73. Central & South America Monoclonal Antibody Service Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Monoclonal Antibody Service Market Share by Application (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Product
Table 83. Roche Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 84. Roche Recent Development
Table 85. Eli Lilly Company Details
Table 86. Eli Lilly Business Overview
Table 87. Eli Lilly Product
Table 88. Eli Lilly Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 89. Eli Lilly Recent Development
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Product
Table 93. Bayer Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 94. Bayer Recent Development
Table 95. Amgen Company Details
Table 96. Amgen Business Overview
Table 97. Amgen Product
Table 98. Amgen Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 99. Amgen Recent Development
Table 100. Sanofi-Aventis Company Details
Table 101. Sanofi-Aventis Business Overview
Table 102. Sanofi-Aventis Product
Table 103. Sanofi-Aventis Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 104. Sanofi-Aventis Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 109. Johnson & Johnson Recent Development
Table 110. Novo Nordisk Business Overview
Table 111. Novo Nordisk Product
Table 112. Novo Nordisk Company Details
Table 113. Novo Nordisk Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 114. Novo Nordisk Recent Development
Table 115. Merck Company Details
Table 116. Merck Business Overview
Table 117. Merck Product
Table 118. Merck Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 119. Merck Recent Development
Table 120. Abbott Laboratories Company Details
Table 121. Abbott Laboratories Business Overview
Table 122. Abbott Laboratories Product
Table 123. Abbott Laboratories Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 124. Abbott Laboratories Recent Development
Table 125. GSK Company Details
Table 126. GSK Business Overview
Table 127. GSK Product
Table 128. GSK Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 129. GSK Recent Development
Table 130. BMS Company Details
Table 131. BMS Business Overview
Table 132. BMS Product
Table 133. BMS Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 134. BMS Recent Development
Table 135. Alexion Company Details
Table 136. Alexion Business Overview
Table 137. Alexion Product
Table 138. Alexion Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 139. Alexion Recent Development
Table 140. UCB Company Details
Table 141. UCB Business Overview
Table 142. UCB Product
Table 143. UCB Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 144. UCB Recent Development
Table 145. Seattle Genetics Company Details
Table 146. Seattle Genetics Business Overview
Table 147. Seattle Genetics Product
Table 148. Seattle Genetics Revenue in Monoclonal Antibody Service Business (2015-2020) (Million US$)
Table 149. Seattle Genetics Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Service Market Share by Type: 2020 VS 2026
Figure 2. Reagents Features
Figure 3. Drugs Features
Figure 4. Other Features
Figure 5. Global Monoclonal Antibody Service Market Share by Application: 2020 VS 2026
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Research & Academic Laboratories Case Studies
Figure 8. Pharmaceutical & Biotechnology Companies Case Studies
Figure 9. Monoclonal Antibody Service Report Years Considered
Figure 10. Global Monoclonal Antibody Service Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Monoclonal Antibody Service Market Share by Regions: 2020 VS 2026
Figure 12. Global Monoclonal Antibody Service Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Monoclonal Antibody Service Market Share by Players in 2019
Figure 15. Global Top Monoclonal Antibody Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Service as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Monoclonal Antibody Service Revenue in 2019
Figure 17. North America Monoclonal Antibody Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Monoclonal Antibody Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Monoclonal Antibody Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Monoclonal Antibody Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Monoclonal Antibody Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Monoclonal Antibody Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Monoclonal Antibody Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
モノクローナル抗体ベース製品の世界市場（～2026年） Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins. This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodie…- バイオシミラーモノクローナル抗体の世界市場（～2026年） Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…
- モノクローナル抗体カスタムサービスの世界市場（～2026年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
- モノクローナル抗体療法の世界市場（～2026年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
- モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…